8h
Hosted on MSNBain Capital buys Mitsubishi Tanabe Pharma for $3.3bnBain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.
The slate deal locks in the Patrick R. Leardo-run investment group as a key partner for the studio as it looks to transition to Skydance Media ownership this year.
Banks are expecting increased M&A activity across the financial sector, but are concerned about acquisition by credit unions ...
Keith Largay joins Bain Capital from JLL, where he spent 14 years and most recently served as co-head of its Chicago office.
U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
Bain Capital entered a deal to acquire Mitsubishi Tanabe Pharma Corporation (MTPC) from Mitsubishi Chemical Group for 510 ...
The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...
Domain also has a co-fi deal with Warner Bros, having a stake in that studio’s highest grossing movie of all-time, Barbie, at ...
Paramount Pictures has entered a slate financing deal with Domain Capital Group that covers a minimum of 30 films.
I Mitsubishi Chemical Group Corporation (MCG) hereby announces that it has resolved, at a meeting of the Board of Directors held today, to ...
Bain Capital has agreed to acquire Tanabe Pharma, the pharma arm of Mitsubishi Chemical Group Corporation. The deal puts Tanabe Pharma at a valuation of about $3.3 billion. Founded in 1678, Tanabe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results